Introduction
============

During our continuous studies on secondary metabolites of the Convolvulaceae, this plant family has been shown to produce a plethora of tropane alkaloids, especially 3-tropanols and their esters (e. g. \[[@b1-scipharm-2013-81-543], [@b2-scipharm-2013-81-543]\]), as well as some 3,6-disubstituted tropanes \[[@b3-scipharm-2013-81-543]\] or the polyhydroxylated calystegines \[[@b4-scipharm-2013-81-543]\]. This underlines the chemotaxonomic relationship with their sister family Solanaceae where the biosynthetic pathway of tropane alkaloids is well investigated. The main route leads to two stereoisomeric 3-hydroxytropanes, namely 3α-tropanol (basic component of the well-known atropine and other esters), and 3β-tropanol which is also precursor of the calystegines. 2-Substituted tropane alkaloids could only be found as a by-product in the Solanaceae \[[@b5-scipharm-2013-81-543]\]. Accordingly, amongst the tropane alkaloids of the Convolvulaceae 2-substituted ones are extremely rare, too, and could only be detected in some *Calystegia*, *Erycibe*, and *Ipomoea* species \[[@b6-scipharm-2013-81-543]\].

Results and Discussion
======================

In the alkaloidal screening of Convolvulaceae via GC-MS analysis the basic extracts of the Australian *Ipomoea velutina* R. B[r]{.smallcaps}. revealed the presence of several unknown substances. In the basic extract of the vegetative parts seven unknown nitrogen-containing compounds were detected: one main alkaloid and six minor ones (0.7--18.7% of the main alkaloid by integration of the corresponding GC-MS peaks). The molecular formula of the main compound (**1**) is consistent with C~15~H~23~NO~4~ (*m/z* 281).

The ^1^H-NMR ([Table 1](#t1-scipharm-2013-81-543){ref-type="table"}) in combination with HSQC and HMBC experiments showed two acylic residues: a C~5~-acid containing a double bond, namely tiglic acid, as well as acetic acid. Both were confirmed by fragmentation ions in the EIMS as products of α-cleavage neighbouring the ester carbonyls: *m/z* 83 (C~4~H~7~−CO^+^; HRMS: \[C~5~H~7~O\]^+^ as 83.04959, calcd. 83.04969) and *m/z* 43 (CH~3~−CO^+^).

The HSQC spectrum revealed a characteristically downfield shifted N−CH~3~ (δ~C~ 40.9, δ~H~ 2.91) as well as three methylene signals (δ~C~ 37.8, 27.5, and 22.8) and four methine groups (δ~C~ 72.9, 70.8, 68.9, and 64.7). From the ^1^H-^1^H-COSY, the complete coupling sequence could be deduced. As a result, **1** ([Fig. 1](#f1-scipharm-2013-81-543){ref-type="fig"}) could be identified as a 2,7-disubstituted tropane.

The substitution pattern of the tropane diester was derived from the mass spectrometric data on the basis of the specific mass fragmentation in bridge-substituted tropanes. The most important fragment is \[M − X−COO−CH=CH~2~\]^+^ after expulsion of the ethylene bridge C-6−C-7 including its substituent; this allows a prediction of the substituents' positions in 3,6/7-disubstituted tropanes \[[@b7-scipharm-2013-81-543], [@b8-scipharm-2013-81-543]\]. Regarding **1**, there are two possible key ions: in case of acetylation in position 7 *m/z* 195 or in case of acetylation in position 2 *m/z* 155. As there is only a veritable peak at *m/z* 195, **1** has to be acetylated in position 7 of the tropane.

The relative stereochemistry of **1** was deduced from characteristic coupling constants: H-7 showed a doublet-doublet with coupling constants of 3.4 Hz and 7.9 Hz that can also be observed in the 7β-substituted schizanthines C--E \[[@b9-scipharm-2013-81-543]\]. This corresponds with the experience that, for steric reasons, bridge substituents usually are *exo*-orientated. H-2 showed a *trans*-diaxial coupling constant *J* = 10 Hz which is -- according to \[[@b10-scipharm-2013-81-543]\] and \[[@b11-scipharm-2013-81-543]\] -- specific for α-orientated substituents at C-2. These conclusions were also confirmed by NOE measurements: H-2 (δ~H~ 5.02) showed correlations to H-1 (δ~H~ 3.55), to the equatorial H-3e (δ~H~ 1.98) and to the axial H-4a (δ~H~ 1.89) which is only possible if H-4a and H-2 are both axial \[[@b11-scipharm-2013-81-543]\]. H-7 (δ~H~ 4.61) was correlated to H-1 (δ~H~ 3.55) and -- only enabled by its *endo*-position -- to the axial H-3a (δ~H~ 1.49) and H-6n (δ~H~ 2.36).

Thus, **1** (ipvelutine) was identified as 7β-acetoxy-2α-(tigloyloxy)tropane.

In the vegetative parts and/or roots, eight minor compounds related to ipvelutine could be detected by GC-MS analysis. They were identified by their fragmentation patterns; characteristic base peaks of those 2,7-disubstituted tropanes are *m/z* 95 and *m/z* 82 or *m/z* 81 together with a prominent peak at *m/z* 156, and of their *nor*tropane derivatives *m/z* 125 and *m/z* 81 including a half-maximal peak at *m/z* 108. An additional result of the systematic GC-MS screening is the detection of ipvelutine (appearing as deacetylated derivative in GC-MS analysis) in vegetative parts of *Convolvulus graminetinus*, *C. sagitattus*, and *Ipomoea abrupta*. Both *Convolvulus* species afforded similar structures, as well, and, additionally, the corresponding *nor*tropanes in the roots. Ipvelutine-related substances were also found in *Ipomoea asarifolia* and *I. plebeia*. The mass fragmentation patterns obtained by GC-MS analysis show that these variations include differences in the stereostructure at C-2 or/and C-7, alternation of the position of the substituents, methylbutyric and hydroxymethylbutyric acid as diverging acyl components, change of the bridge substituents' position from C-7 to C-6 and a hydroxy group as additional substituent (for details see \[[@b12-scipharm-2013-81-543]\]).

2,7-Dihydroxy*nor*tropane showing the same substitution pattern as ipvelutine is also synthesized by root cultures of *Calystegia sepium* (Solanaceae). Incorporation experiments with ^15^N-labelled 3-tropanone revealed that, unless 2,7-dihydroxy*nor*tropane derives the regular tropane alkaloid pathway, it is not an intermediate in calystegine biosynthesis, but can be seen as a by-product \[[@b5-scipharm-2013-81-543]\].

From the pharmacological point of view, the finding of ipvelutine and derivatives is of interest since they show structural similarity to bao gong teng A \[[@b13-scipharm-2013-81-543]\] obtained from the vegetative parts of *Erycibe obtusifolia* (Convolvulaceae). Bao gong teng A is characterized by strong miotic properties and therefore used as an antiglaucoma agent in medicinal products. This pharmacological effect is contradictory to that of atropine/hyoscyamine having significance as a mydriatic in ophthalmology and being one of the most commonly used tropanes of natural origin.

Experimental
============

General procedures
------------------

^1^H-NMR and ^1^H-^1^H-COSY spectra were obtained on a Bruker AMX 400 MHz, HSQC and HMBC spectra on a Bruker DRX 500 MHz (TMS as internal standard). EIMS and HR-EIMS were recorded on a Varian MAT 711 (80 eV), FABMS on a Varian MAT CH~5~DF. The GC-MS system consisted of a Fisons GC 8060 coupled to a quadrupole mass spectrometer Fisons MD 800c.

Plant material
--------------

Roots and vegetative parts of *Ipomoea velutina* R. B[r]{.smallcaps}. grown from seeds collected in the wild at Florence Falls, Litchfield National Park, Northern Territory/Australia, were harvested in the greenhouse of the Institut für Pharmazie, Freie Universität Berlin. A voucher specimen is deposited at the herbarium of the Berlin-Dahlem Botanical Garden -- Botanical Museum (BGBM), Freie Universität Berlin, Germany.

Extraction and isolation of ipvelutine
--------------------------------------

235 g dried and ground vegetative parts of *Ipomoea velutina* were extracted 4 h with 3 L MeOH three times and once with a mixture of 2.4 L MeOH and 600 mL 2% aqueous tartaric acid. After evaporation of the MeOH (50°C i. V.), the residue was redissolved in 600 mL 2% aqueous tartaric acid and extracted with petrol ether, CH~2~Cl~2~, and EtOAc, respectively (3 × 500 mL each). Then, the aqueous layer was alkalinized (pH 10) with aqueous NH~3~ (25%) and extracted with 4 × 500 mL CH~2~Cl~2~. The united alkaline CH~2~Cl~2~ fractions gave 172 mg crude alkaloid fraction which was dissolved in 50 mL 2% aqueous tartaric acid again and extracted with petrol ether, CH~2~Cl~2~, and EtOAc (3 × 50 mL each). After addition of aqueous NH~3~ (pH 10), the aqueous layer was extracted with 4 × 50 mL CH~2~Cl~2~. After drying over Na~2~SO~4~ and evaporation of CH~2~Cl~2~ (40°C i. V.), the alkaline fractions were united and 10 mg ipvelutine were gained (81% purity according to NMR spectra).

### 7β-Acetoxy-2α-(tigloyloxy)tropane \[(1S,2S,5R,7R)-7-(acetyloxy)-8-methyl-8-aza-bicyclo\[3.2.1\]oct-2-yl (2E)-2-methylbut-2-enoate, ipvelutine, **1**\]

Yellow oil. ^1^H-NMR (400 MHz, MeOD): see [Table 1](#t1-scipharm-2013-81-543){ref-type="table"}. ^13^C-NMR (100.6 MHz, MeOD): see [Table 1](#t1-scipharm-2013-81-543){ref-type="table"}. MS (EI, 80 eV, 110°C): *m/z* (%) = 281 (2) \[M\]^+^, 239 (83), 195 (7), 156 (100), 142 (60), 140 (35), 112 (11), 98 (46), 96 (84), 95 (91), 94 (50), 85 (41), 84 (31), 83 (27), 55 (22), 43 (20). (+)-FAB MS (80 eV): *m/z* = 282 \[M+H\]^+^. HR MS (80 eV): *m/z* = 281.16256 (calcd. 281.16271 for C~15~H~23~NO~4~), 239.15283 (calcd. 239.15214 for C~13~H~21~NO~3~), 156.10254 (calcd. 156.10245 for C~8~H~14~NO~2~^+^), 142.08678 (calcd. 142.08681 for C~7~H~12~NO~2~^+^), 140.10749 (calcd. 140.10754 for C~8~H~14~NO^+^), 98.062524 (calcd. 98.06059 for C~5~H~8~NO^+^), 95.072728 (calcd. 95.073499 for C~6~H~9~N).

GC-MS analysis
--------------

Ground plant parts (50 g) were extracted three times with 500 mL MeOH (80%). After evaporation the residue was dissolved in 2% aqueous tartaric acid and extracted with petrol ether, CH~2~Cl~2~, and EtOAc. The aqueous layer was alkalinized and extracted with CH~2~Cl~2~. To purify the extracts obtained, this procedure was repeated with corresponding smaller amounts of the solvents. The resulting extracts were subjected to GC-MS analysis. Samples were injected at 240°C (split 1:20) and separated on a DB-1 column (0.32 mm ×30 m, J&W Scientific, California) by raising temperature from 70°C to 300°C at 6°C/min. Helium was used as carrier gas. Retention indices (RI): Kovats indices \[[@b14-scipharm-2013-81-543]\] were calculated in relation to a set of co-injected hydrocarbons.

The authors are indebted to Ms. U. Ostwald (FU Berlin) for providing the FABMS and HRMS spectra.

This article is available from: <http://dx.doi.org/10.3797/scipharm.1303-13>
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###### 

^1^H- and ^13^C-NMR data of ipvelutine (in MeOD)

  **atom**   **^1^H-NMR (in MeOD)**   **^13^C-NMR[\*](#tfn1-scipharm-2013-81-543){ref-type="table-fn"} (in MeOD)**                              
  ---------- ------------------------ ------------------------------------------------------------------------------ -------------------------- -------
  1          3.55                     *br d*                                                                         3.2 Hz                     72.9
  2a         5.02                     *ddd*                                                                          2.2 Hz; 5.9 Hz; 11.3 Hz    68.9
  3e         1.98                     *m*                                                                                                       22.8
  3a         1.49                     *dtd*                                                                          6.4 Hz; 12.1 Hz; 12.8 Hz   
  4a         1.89                     *m*                                                                                                       27.5
  4e         1.68                     *ddd*                                                                          2.3 Hz; 6.7 Hz; 13.7 Hz    
  5          3.82                     *br t*                                                                         5.2 Hz                     64.7
  6n         2.36                     *dd*                                                                           8.0 Hz; 14.6 Hz            37.8
  6x         2.27                     *ddd*                                                                          3.5 Hz; 6.3 Hz; 14.7 Hz    
  7n         4.61                     *dd*                                                                           3.4 Hz; 7.9 Hz             70.8
  N−CH~3~    2.91                     *s*                                                                                                       40.9
  1'                                                                                                                                            167.8
  2'                                                                                                                                            129.0
  3'         6.96                     *dq*                                                                           1.2 Hz; 6.9 Hz             139.3
  CH~3~−4'   1.83                     *d*                                                                            7.1 Hz                     11.9
  CH~3~−5'   1.84                     *d*                                                                            0.9 Hz                     14.1
  1"                                                                                                                                            176.7
  CH~3~−2"   1.93                     *s*                                                                                                       21.9

...taken from HSQC/HMBC.
